ASP Isotopes Inc
ASPI at a Glance
- Market cap
- $320.4M
- Revenue (TTM)
- $30.9M
- EPS (TTM)
- $-1.44
- 52-week range
- $2 – $11
- Street target
- $13.00
- Next report
- Nov 18, 2026
Headquartered in Dallas, TX Fiscal year ends December NASDAQ: ASPI aspisotopes.com
About ASP Isotopes
ASP Isotopes Inc. is a pioneering materials company in its pre-commercial stage, focusing on creating and selling isotopes for various industries. With a product lineup including Molybdenum-100 for medical applications, Carbon-14, Silicon-28, and Uranium-235 for the carbon-free energy sector, the company is at the forefront of supplying critical components for healthcare and energy. Founded in 2021 and headquartered in Boca Raton, Florida, ASP Isotopes is dedicated to innovation in the isotope market.
Frequently Asked Questions
What does ASP Isotopes do?
ASP Isotopes Inc. is a pioneering materials company in its pre-commercial stage, focusing on creating and selling isotopes for various industries.
What is the ASPI stock price target?
The Wall Street consensus 12-month price target for ASPI is $13.00.